Assistant Secretary for Legislation (ASL)

Testimony

Calendar Year 2003 Congressional Testimony

2007~2006~2005~2004~2003~2002~2001~2000~1999~1998~1997~1996
Jan~Feb~Mar~Apr~May~Jun~Jul~Aug~Sep~Oct~Nov~Dec

November 20, 2003--Peter C. van Dyck, M.D., M.P.H., Associate Administrator of the Maternal and Child Health Bureau
Subject: Hearing: Activities to Support Persons with Autism Spectrum
Before: Subcommittee on Wellness and Human Rights, House Committee on Government Reform, United States House of Representatives

November 20, 2003--John M. Taylor, III, Associate Commissioner for Regulatory Affairs, Food and Drug Administration
Subject: Hearing: Drug Reimportation
Before: The Committee on Commerce, Science and Transportation United States Senate

November 19, 2003--Lester M. Crawford, D.V.M, Deputy Commissioner, Food and Drug Administration
Subject: Hearing: Food Counterterrorism Activities
Before: Committee on Commerce, Science and Transportation United States Senate

November 13, 2003--William Egan, Ph.D., Acting Director, Office of Vaccine Research and Review, Center for Biologics Evaluation and Research, Food and Drug Administration
Subject: Hearing: SV40 in Polio Vaccine
Before: Subcommittee on Wellness and Human Rights, Committee on Government Reform, US House of Representatives

October 30, 2003-- Richard H. Carmona, M.D., M.P.H., F.A.C.S., Surgeon General, U.S. Public Health Service, Department of Health and Human Services
Subject: Hearing: Meeting Our Nation's Important Public Health Challenges: Transformation of the Public Health Service Commissed Corps.
Before: The Committee on Government Reform, United States House of Representatives

October 30, 2003-- John Howard, M.D., J.D., Director, National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention, U.S. Department of Health and Human Services
Subject: Hearing: HHS Activities Under the Energy Employees Occupatoinal Illness Compensation Program Act
Before: The Subcommittee on Workforce Protections, Committee on Education and the Workforce, United States House of Representatives

October 28, 2003-- Diane Porter, Deputy Director, National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention, Department of Health and Human Services
Subject: Hearing: Assessing September 11th Health Effects: What Should Be Done?
Before: The Subcommittee on National Security, Emerging Threats and International Relations, Committee on Government Reform, United States House of Representatives

October 23, 2003-- Steven K. Galson, M.D., M.P.H., Acting Director, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Department of Health and Human Services
Subject: Hearing: Federal and State Role in Pharmacy Compounding and Reconstitution: Exploring the Right Mix to Protect Patients
Before: Senate Committee on Health, Education, Labor, and Pensions

October 8, 2003-- Thomas Scully, Administrator, Centers for Medicaid and Medicare Services, Department of Health and Human Services
Subject: Challenges facing the Medicaid Program in the 21st Century
Before: House Energy and Commerce Committee Subcommittee on Health

October 3, 2003-- Elias Zerhouni, MD, Director, National Institutes of Health, Department of Health and Human Services
Subject: Hearing: Managing Biomedical Research to Prevent and Cure Disease in the 21st Century: Matching NIH Policy with Science
Before: The Committee on Health, Education, Labor and Pensions, Committee on Energy and Commerce

October 1, 2003-- Michel Lincoln, Deputy Director, Indian Health Service
Subject: HR 2440, Indian Health Care Improvement Act Amendments of 2003 and HR 151, To Elevate the Position of Director of the Indian Health Service within the Department of Health and Human Services to Assistant Secretary for Indian Health
Before: The House Resources Committee, Office of Native American and Insular Affairs

October 1, 2003-- Richard H. Carmona, M.D., M.P.H., F.A.C.S., Surgeon General, U.S. Public Health Service, Department of Health and Human Services
Subject: Reshaping America's Health Care for the Future
Before: Joint Economic Committee, United States Congress

October 1, 2003-- William C. Stamper, Deputy Assistant Secretary, Office for Facilities Management and Policy, Department of Health and Human Services
Subject: Deteriorating Government Buildings
Before: The Committee on Government Affairs, United States Senate

September 30, 2003-- Arthur Lawrence, Ph.D, Acting Principal Deputy Assistant Secretary for Health
Subject: Dietary Guidelines for Americans
Before: Subcommitee on Consumer Affairs and Product Safety, Committee on Commerce, Science, and Transportation, United States Senate

September 25, 2003-- Windy M. Hill, Associate Commissioner, Head Start Bureau, U.S. Department Of Health and Human Services
Subject: The President's Plan to Strengthen Head Start
Before: The Senate Committee on Indian Affairs

September 24, 2003-- Charles Grim, D.D.S., M.H.S.A, Director, Indian Health Service
Subject: Congressional Testimony for Charles Grim on September 24, 2003
Before: The Senate Committee on Indian Affairs

September 24, 2003-- Joseph M. Henderson, M.P.A., Director, Office of Terrorism Preparedness and Emergency Response Centers for Disease Control and Prevention, U.S. Department of Health and Human Services
Subject: CDC's Disease Surveillance Systems Efforts
Before: The Subcommittee on Emergency Preparedness and Response, Select Committee on Homeland Security, United States House of Representatives

September 23, 2003-- Jared Adair, Director, Office of HIPAA Standards, Centers For Medicare & Medicaid Services
Subject: HIPAA Transaction And Code Set Requirements
Before: Senate Special Committee On Aging

September 23, 2003-- Richard Campanelli, Director, Office for Civil Rights, U.S. Department of Health and Human Services
Subject: HIPAA Medical Privacy and Transaction Rules: Overkill or Overdue?
Before: The Senate Special Committee on Aging

September 22, 2003-- Richard H. Carmona, M.D., M.P.H., F.A.C.S., Surgeon General, U.S. Public Health Service, Department of Health and Human Services
Subject: Ageism in Healthcare: Are Our Nation's Seniors Receiving Proper Oral Health Care?
Before: Special Committee on Aging, United States Senate

September 10, 2003-- James Goedert, M.D., Chief, Viral Epidemiology Branch, Division of Cancer Edpidemiology and Genetics, National Cancer Institute, National Institutes of Health, U.S. Department of Health and Human Services
Subject: Research on SV 40 Exposure and the Development of Cancer
Before: The Subcommittee on Wellness and Human Rights, Committee on Government Reform, United States House of Representatives

August 1, 2003-- Daniel E. Troy, Chief Counsel, U.S. Food and Drug Administration
Subject: FDA's implementation of the Drug Price Competition and Patent Term Restoration Act of 1984
Before: Senate Committee on the Judiciary

July 31, 2003-- James M. Hughes, M.D., Director, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Department of Health and Human Services
Subject: CDC Preparedness Planning for Severe Acute Respiratory Syndrome (SARS)
Before: Senate Permanent Subcommittee on Investigations, Committee on Governmental Affairs

July 28, 2003-- Jane L. Pearson, Ph.D., Associate Director for Preventive InterventionsChair, NIMH Suicide Research Consortium, National Institute of Mental Health, National Institutes of Health, U.S. Department of Health and Human Services
Subject: NIMH Research on Geriatric Depression and Suicide
Before: Senate Special Committee on Aging

July 24, 2003-- Mark B. McClellan, M.D., Ph.D., Commissioner, Food and Drug Administration
Subject: Regulation of dietary supplements particular those containing: Ephedra or Ephedrine Alkaloids
Before: The Subcommittee on Commerce, Trade and Consumer Protection and The Subcommittee on Oversight and Investigations, Committee on Energy and Commerce

July 24, 2003-- Elias A. Zerhouni, M.D., Director, National Institutes of Health, Department of Health and Human Services
Subject: Federal Biodefense Readiness
Before: The Committee on Health, Education, Labor and Pensions

July 24, 2003-- Mark B. McClellan, M.D., Ph.D., Commissioner of Food and Drug, Food and Drugs Administration, Department of Health and Human Services
Subject: Biodefense Workforce
Before: The Committee on Health, Education, Labor and Pensions

July 22, 2003-- Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research, Food and Drug Administration, Department of Health and Human Services
Subject: FDA Regulates Prescription Drug Promotion
Before: The Senate Special Committee on Aging

July 22, 2003-- Windy M. Hill, Associate Commissioner, Head Start Bureau, Administration on Children, Youth and Families, Administration for Children and Families, Department of Health and Human Services
Subject: Head Start
Before: The Committee on Health , Education, Labor and Pensions, United States Senate

July 22, 2003-- G. Reid Lyon, Ph.D., Chief, Child Development and Behavior Branch, National Institute of Child Health and Human Development, The National Institutes on Health, Department of Health and Human Services
Subject: Head Start
Before: The Committee on Health , Education, Labor and Pensions, United States Senate

July 17, 2003-- Thomas A. Scully, Administrator, Centers for Medicare & Medicaid Services, Dept. of Health and Human Services
Subject: Nursing Home Quality
Before: The Senate Finance Committee

July 17, 2003-- Charles G. Curie, M.A., A.C.S.W., Administrator, Substance Abuse and Mental Health Services Administration, Dept. of Health and Human Services
Subject: Parents of all Socioeconomic Backgrounds
Before: The Senate Committee on Government Affairs, United States Senate

July 17, 2003-- Stephen Ostroff, M.D., M.P.H., Ph.D., Deputy Director, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Dept. of Health and Human Services
Subject: CDC's Role in Zoonotic Disease Outbreaks
Before: The Committee on Environment and Public Works, United States Senate

July 17, 2003-- Lester M. Crawford, D.V.M., Ph.D., Deputy Commissioner, FDA/HHS
Subject: FDA's Role in the National Response to an Emerging Zoonotic or Secondarily Transmitted Infectious Disease
Before: The Committee on Environment and Public Works, United States Senate

July 16, 2003-- Charles W. Grim, D.D.S, M.H.S.A, Interim Director, Indian Health Service
Subject: The Reauthorization Of The Indian Health Care Improvement Act
Before: The Senate Committee On Indian Affairs And The House Resources Committee, Office of Native American And Insular Affairs

July 16, 2003-- Richard H. Carmona, M.D., M.P.H., F.A.C.S., Surgeon General, U.S. Public Health Science, Acting Assistant Secretary for Health, Department of Health and Human Services
Subject: The Obesity Crisis in America
Before: The Subcommittee on Education Reform, Committee on Education and the Workforce, United States House of Representatives

July 15, 2003-- Charles G. Curie, M.A., A.C.S.W., Administrator, Substance Abuse and Mental Health Services Administration, US Department of Health and Human Services
Subject: Senate Health, Education, Labor, and Pensions Subcommittee on Substance Abuse and Mental Health Services
Before: Subcommittee Hearing on the Reauthorization of SAMHSA

July 10, 2003-- Dr. Wade F. Horn, Assistant Secretary for Children and Families, Department of Health and Human Services
Subject: Re-Authorization of the Community Services Block Grant Program
Before: The Senate Committee on Health, Education, Labor, and Pensions

July 9, 2003-- Mark B. McClellan, M.D., Ph.D., Commissioner of Food and Drugs
Subject: Technology and Innovation: Their Effects on Cost Growth of Healthcare
Before: The Joint Economic Committee

June 24, 2003-- William K. Hubbard, Associate Commisioner for Policy and Planning, Department of Health and Human Services and John M. Taylor, III, Associate Commissioner for Regulatory Affairs, Food and Drug Administration
Subject: The Avalanche of Imported, Counterfeit and Unapproved Drugs in the U.S.
Before: The Subcommittee on Oversight and Investigations, Committee on Energy and Commerce - House of Representatives

June 24, 2003-- Allen M. Spiegel, M.D., National Institute of Diabetes and Digestive and Kidney Diseases
Subject: Juvenile Diabetes - Examining the Personal Toll on Families, Financial Costs to the Federal Health Care System, and Research Progress Toward a Cure
Before: Senate Committee on Governmental Affairs

June 17, 2003-- J. Carl Barrett, Ph.D., Director, National Cancer Institute, National Institutes of Health, Department of Health and Human Services
Subject: Reserch on Molecular Targets to Diagnose, Prevent and Treat Cancer
Before: The Senate Cancer Coalition, United States Senate

June 17, 2003-- Lester M. Crawford, D.V.M., Ph.D., Deputy Commissioner, Food and Drug Administration, Department of Health and Human Services
Subject: Regulatory Program of The Food and Drug Administration (FDA)
Before: Subcommittee on Conservation, Credit, Rural Development and Research, Committee on Agriculture, United States of Representatives

June 17, 2003-- Daniel E. Troy, Chief Counsel, Food and Drug Administration, Department of Health and Human Services
Subject: The Federal Trade Commission's July 2002 Report entitled "Generic Drug Entry Prior to Patent Expiration"
Before: Committee on Judiciary, Unites States Senate

June 12, 2003-- William K. Hubbard, Associate Commissioner For Policy and Planning
Subject: Canadian Prescription Drug Re-Improtation: Is There a Safety Issue?
Before: Committee on Government Reform, Subcommittee onHuman Rights and Wellness/ U.S. House of Representatives

June 11, 2003-- Wade F. Horn, Ph.D., Assistant Secretary for Children and Families Department of Health and Human Services
Subject: President's Proposal for Improving Child Welfare
Before: Committee on Ways and Means, Subcommittee on Human Resources, U.S. House of Representatives

June 6, 2003-- Ali S. Khan, M.D., M.P.H., Associate Director for Science Division of Parasitic Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Department of Health and Human Services
Subject: Public Health Assessment of Potential Biological Terrorism Agents
Before: House Select Committee on Homeland Security

June 6, 2003-- John R. LaMontagne, Ph.D., Deputy Director, National Institute of Allergy and Infectious Diseases, National Institutes of Health, U.S. Department of Health and Human Services
Subject: Developing Medical Countermeasures Against Bioterrorist Threats
Before: House Select Committee on Homeland Security

June 6, 2003-- Thomas A. Scully, Administrator, Centers for Medicare and Medicaid Services
Subject: Strengthening and Improving the Medicare Program
Before: Senate Finance Committee

June 3, 2003-- Michelle Synder, Director, Office of Special Programs Health Resources and Services Administration (HRSA)
Subject: Assessing Initiatives to Increase Organ Donations
Before: Subcommittee on Oversight and Investigations, House Energy and Commerce Committee, U. S. House of Representatives

June 3, 2003-- Richard H. Carmona, M.D., M.P.H., F.A.C.S., Surgeon General, U.S. Public Health Service, Acting Assistant Secretary for Health, Department of Health and Human Services
Subject: Can Tobacco Cure Smoking? A Review of Tobacco Harm Reduction
Before: House Subcommittee on Commerce, Trade, and Consumer Protection, Committee on Energy and Commerce

June 3, 2003-- Scott J. Leischow, Ph.D., Chief, Tobacco Control Research Branch, National Cancer Institute, National Institutes of Health, U.S. Department of Health and Human Services
Subject: The Science of Reduced Risk Tobacco Products
Before: House Committee on Government Reform

May 29, 2003-- Joseph Henderson, Associate Director for Terrorism Preparedness and Emergency Response, Centers for Disease Control and Prevention, U.S. Department of Health and Human Services
Subject: CDC's Terrorism Preparedness and Emergency Response Program
Before: Committee on Veterans, Homeland Security and Military Affairs, New York State Senate

May 22, 2003-- Muin Khoury, M.D., Ph.D., Director, Office of Genomics and Disease Prevention, Centers for Disease Control and Prevention, Department of Health and Human Services
Subject: Genomics Research in the 21st Century: From the Test Tube to Population Health
Before: Subcommittee on HealthCommittee on Energy and Commerce United States House of Representatives

May 22, 2003-- Francis S. Collins, M.D., Ph.D, Director, National Human Genome Research Institute, National Institutes of Health, Department of Health and Human Services
Subject: The Future of Genomics
Before: The Subcommittee on Health, Committee on Energy and Commerce United States House of Representatives

May 20, 2003-- Elias Zerhouni, M.D., Director, National Institute of Health, Department of Health and Human Services
Subject: Stem Cell Research
Before: The Senate Appropriations Subcommittee on Labor, HHS, Education

May 20, 2003-- Josefina G. Carbonell, Assistant Secretary for Aging Department of Health and Human Services
Subject: Baby Boomers at the Gate: Enhancing Independence through Innovation and Technology
Before: The Special Committee on Aging

May 19, 2003-- Capt. Kenneth F. Martinez, MSEE, CIH, Supervisory Industrial Hygienist, National Institute for Occupational Safety and Health Centers for Disease Control and Prevention, Department of Health and Human Services
Subject: CDC and ATSDR Activities at the SOuthern Connecticut Processing and Distribution Center in Wallingfor, CT
Before:The Committee on Government Reform Sub-Committee on National Security, Emerging Threats, and International Relations -- United States House of Representatives

May 19, 2003-- James S. Marks, M.D., M.P.H., Director National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Department of Health and Human Services
Subject: Preventing Disease and Preserving Health Among Our Nation's Aging
Before:The Special Committee on Aging - United States Senate

May 15, 2003-- Anthony S. Fauci, M.D., Director, National Institute of Allergy and Infectious Diseases, Department of Health and Human Services
Subject: BioShield: Countering the Bioterrorist Threat
Before: The Select Committee on Homeland Security United States House of Representatives

May 7, 2003-- Anthony S. Fauci, M.D., Director, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services
Subject: NIH's Response to the Global Outbreak of Severe Acute Respiratory Syndrome (SARS)
Before: House Subcommittee on Oversight and Investigations, Committee on Energy and Commerce

May 7, 2003-- Julie L. Gerberding, M.D., M.P.H., Director, Centers for Disease Control and Prevention, Department of Health and Human Services
Subject: CDC Response to Severe Acute Respiratory Syndrome (SARS)
Before: House Subcommittee on Oversight and Investigations, Committee on Energy and Commerce

May 7, 2003-- Jerome M. Hauer, M.H.S., Acting Assistant Secretary for Public Health Emergency Preparedness, U.S. Department of Health and Human Services
Subject: Combating the SARS Outbreak
Before: House Subcommittee on Oversight and Investigations, Committee on Energy and Commerce

May 7, 2003-- Murray M. Lumpkin, M.D., M.Sc., Principal Associate Commissioner, Food and Drug Administration, U.S. Department of Health and Human Services
Subject: FDA Efforts to Combat the SARS Outbreak
Before: House Subcommittee on Oversight and Investigations, Committee on Energy and Commerce

May 7, 2003-- Tommy G. Thompson, Secretary, Department of Health and Human Services
Subject: HHS's Role in Combating the Global Spread of HIV/AIDS
Before: House Subcommittee on Foreign Operations,Export Financing and Related Programs, Committee on Appropriations

May 5, 2003-- David Fleming, M.D., Deputy Director for Public Health Science, Centers for Disease Control and Prevention, Department of Health and Human Services
Subject: CDC's Public Health Surveillance Activities
Before: The United States House of Representatives Committee on Governmnet Reform, Subcommittee on National Security, Emerging Threats, and International Relations

May 1, 2003-- William Raub, Ph.D., Acting Assistant Secretary for Planning and Evaluation, U.S. Department of Health and Human Services
Subject: Services Funded by Department of Health and Human Services
Before:The Committee of Transportatoin and Infrastructure and the Committee on Education and the Workforce - House of Representatives

May 1, 2003-- Department of Health and Human Services, National Institutes Of Health
Subject: Statement for the Record on Nanotechnology
Before:Senate Committee on Commerce, Science, and Transportation

April 29, 2003-- Julie L. Gerberding, M.D., M.P.H., Director, Centers for Disease Control and Prevention Department of Health and Human Services
Subject: CDC Response to Severe Acute Respiratory Syndrome (SARS)
Before: Committee on Health, Education, Labor, and Pensions United States Senate

April 10, 2003-- Jerome M. Hauer, M.H.S., Acting Assistant Secretary for Public Health Emergency Preparedness, U.S. Department of Health and Human Services
Subject: Weapons of Mass Destruction: Is Our Nation's Medical Community Ready?
Before: United States House of Representatives Subcommittee on Oversight and Investigations Committee on Veterans Affairs

April 9, 2003-- William Raub, Acting Assistant Secretary, Planning and Evaluation, Department of Health & Human Services
Subject: S. 285, "Native American Alcohol and Substance Abuse Program Consolidation Act"; S.555, "Native American Health and Wellness Foundation Act"; and S.558, IHS Director Elevation Bill
Before: Senate Committee On Indian Affairs

April 9, 2003-- Richard S. Foster, F.S.A., Chief Actuary, Centers for Medicare and Medicaid Services/HHS
Subject: The Financial Outlook for Medicare
Before: House Committee on Energy and Commerce Subcommittee on Health

April 9, 2003-- Tommy G. Thompson Secretary, Department of Health and Human Services
Subject: HHS's Response to Severe Acute Respiratory Syndrome (SARS)
Before: House Committee on Government Reform

April 8, 2003-- Wade F. Horn, Ph.D., Assistant Secretary for Children and Families, U.S. Department of Health and Human Services
Subject: Adoption and Safe Families Act of 1997
Before: Committee on Ways and Means, Subcommittee on Human Resources, U.S. House of Representatives

April 7, 2003-- Julie L. Gerberding, M.D., M.P.H., Director Centers for Disease Control and Prevention, HHS
Subject: CDC Response to Severe Acute Respiratory Syndrome (SARS)
Before: The Committee on Health, Education, Labor and Pensions United States Senate

April 7, 2003-- Anthony S. Fauci, M.D., Director National Institute of Allergy and Infectious Diseases
National Institutes of Health
Department of Health and Human Services
Subject: NIH's Promising Research on Severe Acute Respiratory Syndrome (SARS)
Before: The Committee on Health, Education, Labor, and Pensions United States Senate

April 3, 2003-- William K. Hubbard Associate Commissioner for Policy, Planning, and Legislation
Subject: "International Prescription Drug Parity; Are Americans Being Protected or Gouged?"
Before: The Committee on Government Reform; Subcommittee on Human Rights and Wellness

April 3, 2003-- Carolyn Clancy, MD Director Agency for HealthCare Research and Quality
Subject: Fiscal Year 2004 Budget Request
Before: The House Subcommittee on Labor-HHS-Education Appropriations

April 3, 2003-- Thomas A. Scully, Administrator, Centers for Medicare & Medicaid Services/HHS
Subject: Fiscal Year 2004 Budget Request
Before: The House Subcommittee on Labor-HHS-Education Appropriations

April 2, 2003-- Ellias Zerhouni, Director National Institute of Health/ HHS
Subject: Fiscal Year 2004 President's Budget Request
Before: The House Subcommittee on Labor-HHS-Eduction Appropriations

March 27, 2003-- Kenneth Olden, Ph.D. Director National Institute of Environmental Health Services
Subject: Fiscal Year 2004 Budget Request
Before: The House Appropriations Subcommittee for Veterans Affairs, Housing and Urban Development and Independent Agencies

March 27, 2003-- William K. Hubbard, Associate Commissioner for Policy, Planning, and Legislation at the Food and Drug Administration (FDA)
Subject: The Domestic Sale of Prescription Drugs over the Internet
Before: House Committee on Government Reform

March 27, 2003-- Tommy G. Thompson, Secretary, Department of Health and Human Services
Subject: Project Bioshield (Opening Statement)
Before: Committee on Energy and Commerce Subcommittee on Health & Committee on Homeland Security Subcommittee on Emergency Preparedness and Response

March 27, 2003-- Julie Louise Gerberding, MD, M.P.H, Director Centers for Disease Control and Prevention Administrator, Agency for Toxic Substances and Disease Registry
Subject: President's Budget Request for Fiscal Year 2004)
Before: House Subcommittee on Labor-HHS-Education Appropriations

March 27, 2003-- Tommy G. Thompson, Secretary, Department of Health and Human Services
Subject: Project Bioshield
Before: Committee on Energy and Commerce Subcommittee on Health & Committee on Homeland Security Subcommittee on Emergency Preparedness and Response

March 26, 2003-- Elizabeth M. James Duke, Ph.D., Administrator, Health Resources and Services Administration
Subject: Fiscal Year 2004 President's Budget Request for the Hearth Resources and Services Administration
Before: The House Appropriations Subcommittee on Labor, Health and Human Srvices and Education

March 26, 2003-- Charles G. Curie, M.A., A.C.S.W., Administrator, Substance Abuse and Mental Health Services Administration, Department of Health and Human Services
Subject: President's FY 2004 Budget for SAMHSA
Before: The House Appropriations Subcommittee on Labor, Health and Human Services and Education

March 25, 2003-- Wade F. Horn, Ph.D., Assistant Secretary, Administration for Children and Families
Subject: Fiscal Year 2004 President's Budget for ACF
Before: The House Committee on Appropriations, Subcommittee on Labor, Health and Human Services and Education

March 25, 2003-- Josefina G. Carbonell, Assistant Secretary for Aging, Administration on Aging
Subject: Fiscal Year 2004 President's Budget for AOA
Before: The House Committee on Appropriations, Subcommittee on Labor, Health and Human Services

March 20, 2003-- Henry Falk, M.D., M.P.H., Assistant Administrator, Agency for Toxic Substance and Disease Registry, Public Health Service, Department of Health and Human Services
Subject: Fiscal Year 2004 Budget Request for ATSDR
Before: The Committee on Appropriations

March 20, 2003-- Tommy G. Thompson, Secretary, Department of Health and Human Services
Subject: President's FY 2004 Budget for Department of Health and Human Services
Before: The U.S. House of Represenatives Labor, HHS/ED Appropriations Subcommittee

March 19, 2003-- Tommy G. Thompson, Secretary, Department of Health and Human Services
Subject: President's FY 2004 Budget for Department of Health and Human Services
Before:U. S. Senate Labor/HHS/ED Appropriations Subcommittee

March 13, 2003-- Claude A. Allen, Deputy Secretary; Department of Health and Human Services
Subject: Addressing the New Health Care Crisis: Reforming the Medical Litigation System to Improve the Quality of Health Care
Before: The United States Senate Committee on Appropriations, Subcommittee on Labor, Health and Human Services and Education

March 12, 2003-- Tommy G. Thompson, Secretary, Department of Health and Human Services
Subject: Welfare Reform: Building on Success
Before: The Committee on Finance -- United States Senate

March 11, 2003-- Lynn C. Swann, Chairman; President's Council on Physical Fitness and Sports/OPHS/HHS
Subject: It's Never Too Late To Move for Health
Before: The Special Committee on Aging -- United States Senate

March 11, 2003-- Judith A. Salerno, M.D., M.S., Deputy Director; National Institutes of Aging/NIH/HHS
Subject: Fitness and Nutrition: The Prescription for Healthy Aging
Before: The Special Committee on Aging -- United States Senate

March 11, 2003-- Thomas A. Scully, Administrator/Centers for Medicare & Medicaid Services/HHS
Subject: Medicare Paymnet for Hospital Outliers
Before: The Senate Appropriations Subcommittee on Labor, Health and Human Services and Education

March 10, 2003-- John M. Taylor, Associate Commissioner for Regulatory Affairs, Food and Drug Administration
Subject: South Florida Access to Affordable Prescription Drugs: Costs and Benefits of Alternative Solutions
Before: House Subcommittee on Oversight and Investigations, Committee on Energy and Commerce

March 6, 2003-- Wade F. Horn, Ph.D., Assistant Secretary for Children And Families, U.S. Department of Health and Human Services
Subject: The President's Plan to Strengthen Head Start
Before: House Subcommittee on Education Reform, Committee on Education and the Workforce

February 27, 2003-- Tommy G. Thompson, Secretary, Department of Health and Human Services
Subject: President's FY 2004 budget for the Department of Health and Human Services (HHS)
Before: United States Senate Committee On Finance

February 26, 2003-- Tommy G. Thompson, Secretary, Department of Health and Human Services
Subject: President's FY 2004 budget for the Department of Health and Human Services (HHS)
Before: United States Senate Committee On Budget

February 26, 2003-- Tommy G. Thompson, Secretary, Department of Health and Human Services
Subject: President's FY 2004 budget for the Department of Health and Human Services (HHS)
Before: U.S. House of Representatives Committee On Budget

February 25, 2003-- Stuart Guterman, Director, Office of Research, Development and Information Centers for Medicare & Medicaid Services
Subject: Eliminating Barriers To Chronic Care Management In Medicare
Before: House Ways & Means Subcommittee On Health

February 17, 2003-- Julie L. Gerberding, M.D., M.P.H., Director, Centers for Disease Control and Prevention, Department of Health and Human Services
Subject: CDC's Role in Promoting Healthy Lifestyles
Before: Senate Committee on Appropriations, Subcommittee on Labor, HHS, Education and Related Agencies

February 13, 2003-- Thomas A. Scully, Administrator, Centers for Medicare & Medicaid Services
Subject: Medicare Regulatory and Contracting Reform
Before: House Ways & Means Subcommittee on Health

February 13, 2003-- Tommy G. Thompson, Secretary, Department of Health and Human Services
Subject: President's FY 2004 budget for the Department of Health and Human Services (HHS)
Before: House Committee on Energy and Commerce

February 6, 2003-- Tommy G. Thompson, Secretary, Department of Health and Human Services
Subject: President's FY 2004 budget for the Department of Health and Human Services (HHS)
Before: House Committee On Ways And Means

January 30, 2003-- Anthony S. Fauci, M.D., Director, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services
Subject: NIH's Role in Implementing A Smallpox Vaccination Program
Before: Senate Committee on Health, Education, Labor, and Pensions

January 30, 2003-- Julie L. Gerberding, M.D., M.P.H., Director, Centers for Disease Control and Prevention, Department of Health and Human Services
Subject: CDC Efforts in Implementing a Smallpox Vaccination Program
Before: Senate Committee on Health, Education, Labor, and Pensions

January 29, 2003-- Anthony S. Fauci, M.D., Director, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services
Subject: NIH's Role in Implementing A Smallpox Vaccination Program
Before: Senate Subcommittee on Labor, HHS, Education and Related Agencies, Committee on Appropriations

January 29, 2003-- Julie L. Gerberding, M.D., M.P.H., Director, Centers for Disease Control and Prevention, Department of Health and Human Services
Subject: CDC Efforts in Implementing a Smallpox Vaccination Program
Before: Senate Subcommittee on Labor, HHS, Education and Related Agencies, Committee on Appropriations

Last Revised: January 30, 2007